03:39 PM EDT, 10/15/2025 (MT Newswires) -- Health care stocks advanced late Wednesday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each adding 0.3%.

The iShares Biotechnology ETF (IBB) climbed 1.6%.

In corporate news, Omeros ( OMER ) shares more than doubled after the company signed an asset purchase and license deal for its zaltenibart drug, under development to treat rare blood and kidney disorders, with Novo Nordisk ( NVO ) for up to $2.1 billion. Novo shares rose 0.2%.